d) (Vollzeit | Mannheim)

Posted on 30. November 2022 by Firma faCellitate

We are looking for a dedicated, enthusiastic self-motivated Key Account Manager (m/f/d) to join our fast-paced and sociable start-up team. Our values – our culture: diversity – flexibility – innovation – customer orientation – entrepreneurial challenge Our mission: contributing to a world without animal experiments in drug research. As global start-up company we are producing a multiplicity of customizable Read more about Key Account Manager (m/f/d) (Vollzeit | Mannheim)[…]

faCellitate appoints Christoph Petry, Ph.D. to become Managing Director and CEO

Posted on 30. November 202230. November 2022 by Firma faCellitate

faCellitate GmbH has appointed Dr. Christoph Petry, as Managing Director and CEO. Dr. Petry spun-out Sividon Diagnostics from Siemens Healthcare in 2010. Serving as Sividon’s CEO he oversaw the development of EndoPredict, a new standard to target breast cancer therapy and later successfully sold the company to Myriad Genetics. As a Managing Director he then Read more about faCellitate appoints Christoph Petry, Ph.D. to become Managing Director and CEO[…]

faCellitate Starts Marketing New 384-well Spheroid Microplate

Posted on 11. October 2022 by Firma faCellitate

faCellitate expands its BIOFLOAT™ coated microplate portfolio by a 384 well format specifically designed for spheroid culture The exceptional performance of the BIOFLOAT™ coating combined with the high density 384-format makes the new product solution particularly valuable for high-throughput spheroid screening Accelerated assays due to spheroid culture without centrifugation and unique spheroid quality – experts Read more about faCellitate Starts Marketing New 384-well Spheroid Microplate[…]

faCellitate, a BASF spin-off, closes a €3.7m seed round led by SARSTEDT and HTGF

Posted on 7. September 2022 by Firma faCellitate

Closing of seed round completed raising €3.7 million from SARSTEDT, High-Tech Gründerfonds (HTGF), R3 Consulting, ARVE Capital, ROI Verwaltungsgesellschaft and Chemovator. faCellitate has developed an intelligent and ultra-low attachment polymer surface coating platform. The first launched product thereof is targeting 3D cell culture, enabling simple, reliable, and reproducible 3D cell cultivation that challenges the industry’s Read more about faCellitate, a BASF spin-off, closes a €3.7m seed round led by SARSTEDT and HTGF[…]